미얀마의 말라리아, 결핵 및 간염의 표준 진단법 및 치료법 현황
Current Status of Standard Diagnostics and Treatment for Malaria, Tuberculosis, and Hepatitis in Myanmar
1
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
말라리아, 결핵, 간염은 미얀마의 중요한 감염 질환으로, 퇴치를 위한 노력에도 불구하고 여전히 심각한 상황이다. 곤충 매개 질환의 하나인 말라리아는 관리 목표치에 도달하여 관리가 잘 이루어지고 있음을 보여주고 있다. 하지만 결핵은 과거 수십년간 오히려 증가하고 있으며, 만성 바이러스성 간염은 주변 국가들에 비해 여전히 높은 수준이다. 이들 감염 질환을 통제하는데 중요한 방법은 조기 진단과 치료이다. 저자들은 최근 4년간 KOICA의 지원으로 미얀마의 주요 감염병의 실태를 파악하고, 감염병 퇴치를 위한 노력을 기울여 왔다. 지금은 이동 수단의 발달로 인해 감염병의 전파에서 국경의 한계가 없어졌기에, 세계 어느 곳에서의 감염도 다른 지역의 사람들에게 끼치는 영향이 크다. 비록 우리나라에서 멀리 떨어진 곳이기는 하나, 미얀마의 감염병 퇴치 노력이 우리나라와 전 세계의 인류 보건 향상에 중요한 영향을 끼칠 것으로 생각한다.
Abstract
Malaria, tuberculosis, and hepatitis are common and notorious infectious diseases in Myanmar. Despite intensive efforts to control these diseases, their prevalence remains high. For malaria, which is a vector-borne disease, a remarkable success in the reduction of new cases has been achieved. However, the annual number of tuberculosis cases has increased over the last few decades, and the prevalence of chronic viral hepatitis infection has been high in Myanmar and other nearby countries. Early detection and prompt treatment are crucial to control these diseases. We have devoted our research efforts to understanding the status of these infectious diseases and working towards their eventual elimination for the last four years with the support of the Korea International Cooperation Agency. In the modern era, an infection that develops in one geographical area can spread globally because national borders do not effectively limit disease transmission. Our efforts to understand the status of infectious diseases in Myanmar will benefit not only Myanmar but also neighboring countries such as Korea.
참고문헌 (30)
- "World Development Indicators 2014 (Myanmar)" (2014)[URL]
- Kwon S, "International Cooperation for Health Sector Development in Myanmar" (2014), Korea Institute for International Economy Policy, and Market Economic Research Institute
- Ministry of Health, "Health in Myanmar, 2013", Ministry of Health, The Union of The Republic of Myanmar, ~ (2013)
- National Health Plan (2006-2011), , Ministry of Health, The Union of The Republic of Myanmar, ~ (2006)
- Cho HK, "Sorafenib suppresses hepatitis B virus gene expression via inhibiting JNK pathway", Hepatoma Res, 1, pp.97~103 (2015)
- Wah Wah Aung, "Phenotypic and Genotypic Analysis of Anti-Tuberculosis Drug Resistance in Mycobacterium tuberculosis Isolates in Myanmar", Annals of Laboratory Medicine, 35(5), pp.494~499 (2015), 대한진단검사의학회
- 미야트 투트 뉴느트, "Effective High-Throughput Blood Pooling Strategy before DNA Extraction for Detection of Malaria in Low-Transmission Settings", The Korean Journal of Parasitology, 54(3), pp.253~259 (2016), 대한기생충학ㆍ열대의학회
- Phyu Win Ei, "Molecular Strain Typing of Mycobacterium tuberculosis: a Review of Frequently Used Methods", Journal of Korean Medical Science, 31(11), pp.1673~1683 (2016), 대한의학회
- Ministry of Health, "Health in Myanmar, 2014", Ministry of Health, The Union of The Republic of Myanmar, ~ (2014)
- Vector Borne Diseases Center Report 2014, , Ministry of Health, The Union of The Republic of Myanmar, ~ (2014)
- "Strategic framework for artemisinin resistance containment in Myanmar (MARC) 2011-2015" (2011)[URL]
- Kyaw MP, "Reduced susceptibility of Plasmodium falciparum to artesunate in southern Myanmar", PLoS One, 8, pp.e57689~ (2013)
- Nyunt MH, "Molecular assessment of artemisinin resistance markers, polymorphisms in the K13 propeller, and a multidrug-resistance gene in the eastern and western border areas of Myanmar", Clin Infect Dis, 60, pp.1208~1215 (2015)
- "Developing a national strategy for malaria elimination in Myanmar" (2015)[URL]
- "Strategy for malaria elimination in the Great er Mekong Subregion (2015–2030)" (2015)[URL]
- "Global TB report 2015" (2015)[URL]
- National TB program Myanmar. Annual report 2013, "Ministry of Health, Myanmar", Ministry of Health, The Union of The Republic of Myanmar, ~ (2013)
- National TB Controllers Association, "Guide to the application of genotyping to tuberculosis prevention and control", US Department of Health and Human Services, ~ (2004)
- "Guidelines for the management of MDR-TB in Myanmar" (2013)[URL]
- "The Operational Strategy 2016-2020"[URL]
- "Prevention and Control of Viral Hepatitis Infection: Framework for Global Action" (2012)[URL]
- Mohd Hanafiah K, "Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence", Hepatology, 57, pp.1333~1342 (2013)
- Jacobsen KH, "Hepatitis A virus seroprevalence by age and world region, 1990 and 2005", Vaccine, 28, pp.6635~6637 (2010)
- "Viral hepatitis in the World Health Organization South-East Asia Region" (2011)[URL]
- "Regional strategy for the prevention and control of viral hepatitis" (1998)[URL]
- Khin M, "Bibliography of research findings on liver diseases in Myanmar" (2005), Department of Medical Research, The Union of The Republic of Myanmar
- Kyi KP, "Viral hepatitis in Myanmar", DMR Bulletin, 9, pp.1~31 (1995)
- Lwin AA, "Prevalence of hepatitis B and C infection in Myanmar", 44th Myanmar Health Congress Program 2016, pp.27~ (2016)
- Shinji T, "Analysis of HCV genotypes from blood donors shows three new HCV type 6 subgroups exist in Myanmar", Acta Med Okayama, 58, pp.135~142 (2004)
- Win KM, "Hepatitis C tratment in Myanmar", Singapore Hepatitis Conference 2015 (2015)